Abstract:Background: DDX3 is a protein with RNA helicase activity that is involved in a variety of biological processes, and it is an important protein target for the development of broad-spectrum antiviral drugs, multiple cancers and chronic inflammation. Objective: The objective of this study is to establish a simple and efficient method to express and purify DDX3 protein in E. coli, and the recombinant DDX3 should maintain helicase activity for further tailor-made screening and biochemical function validation. Methods: DDX3 cDNA was simultaneously cloned into pET28a-TEV and pNIC28-Bsa4 vectors and transfected into E. coli BL21 (DE3) to compare one suitable prokaryotic expression system. The 6×His-tag was fused to the C-terminus of DDX3 to form a His-tagging DDX3 fusion protein for subsequent purification. Protein dissolution buffer and purification washing conditions were optimized. The His-tagged DDX3 protein would bind with the Ni-NTA agarose by chelation and collected by affinity purification. The 6×His-tag fused with N-terminal DDX3 was eliminated from DDX3 by TEV digestion. A fine purification of DDX3 was performed by gel filtration chromatography. Results: The recombinant plasmid pNIC28-DDX3, which contained a 6×His-tag and one TEV cleavage site at the N terminal of DDX3 sequence, was constructed for DDX3 prokaryotic expression and affinity purification based on considering the good solubility of the recombinant His-tagging DDX3, especially under 0.5 mM IPTG incubation at 18 °C for 18 h to obtain more soluble DDX3 protein. Finally, the exogenous recombinant DDX3 protein was obtained with more than 95% purity by affinity purification on the Ni-NTA column and removal of miscellaneous through gel filtration chromatography. The finely-purified DDX3 still retained its ATPase activity. Conclusion: A prokaryotic expression pNIC28-DDX3 system is constructed for efficient expression and affinity purification of bioactive DDX3 protein in E. coli BL21(DE3), which provides an important high-throughput screening and validation of drugs targeting DDX3.

Expression of Drosophila Dxl6 N-domain in E. Coli BL21 ( DE3 )

Heterologous Expression and Purification of Dermaseptin S4 Fusion in Escherichia Coli and Recovery of Biological Activity.

Cloning and Expression of doxA Gene Encoding Daunorubicin C-14 Hydroxylase in E.coli and Its Purification

Prokaryotic Expression and Affinity Purification of DDX3 Protein

Expression of 5401 gene of Eimeria tenella ZJ Strain in E.coli BL21

Expression of E.tenella ZJ strain 3-1E gene in E.coli

Enhanced Expression and Primary Purification of Soluble HBD3 Fusion Protein in Escherichia coli

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

Efficient expression and primary purification of 6-his tagged human Fas ligand in Dictyostelium discoideum

High-level Expression of Soluble Human Β-Defensin-2 in Escherichia Coli

[Prokaryotic Expression, Purification and Identification of VEGFR2 D3.4/GST Fusion Protein in E.coli].

Tandem Repeat Mhbd2 Gene Enhance the Soluble Fusion Expression of Hbd2 in Escherichia Coli

Bacterial Expression of the HINab Domain of IFI16: Purification, Characterization of DNA Binding Activity, and Co-Crystallization with Viral Dsdna

Efficient expression of membrane-bound water channel protein (Aquaporin Z) in Escherichia coli.

EXPRESSING HUMAN MATURED BRAIN-DERIVED NEUROTROPHIC FACTOR GENE IN E.Coli AND DETERMINING ITS BIOACTIVITY

Cloning,expression and Purification of the Important NIDO Domain Protein

Preferential codons enhancing the expression level of human beta-defensin-2 in recombinant Escherichia coli.

Expression of Protein P40 in E Coli and Primary Purification

Expression of Nonfusion Extracellular Porcine Zona Pellucida Protein 3β in E.coli

CLONING AND EXPRESSING OF TRANSGLUTAMINASE GENE IN E. COLI

Construction of GST-C/EBPα Fusion Protein Expression Vectors and the Expressions in Escherichia coli